ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID
NODE_45_length_63428_cov_9.51923_39 # 41997 # 42797 # -1 # ID=45_39;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=10bp;gc_cont=0.340	NODE_45_length_63428_cov_9.51923_39	41997	42797	-	Strict	400	535.798	ErmF	99.25	3000498	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACAAAAAAGAAATTGCCCGTTCGTTTTACGGGTCAGCACTTTACTATTGATAAAGTGCTAATAAAAGATGCAATAAGACAAGCAAATATAAGTAATCAGGATACGGTTTTAGATATTGGGGCAGGCAAGGGGTTTCTTACTGTTCATTTATTAAAAATCGCCAACAATGTTGTTGCTATTGAAAACGACACAGCTTTGGTTGAACATTTACGAAAATTATTTTCTGATGCCCGAAATGTTCAAGTTGTCGGTTGTGATTTTAGGAATTTTGCAGTTCCGAAATTTCCTTTCAAAGTGGTGTCAAATATTCCTTATGGCATTACTTCCGATATTTTCAAAATCCTGATGTTTGAGAGTCTTGGAAATTTTCTGGGAGGTTCCATTATCCTTCAATTAGAACCTACACAAAAGTTATTTTCGAGGAAGCTTTACAATCCATATACCGTTTTCTATCATACTTTTTTTGATTTGAAACTTGTCTATGAGGTAGGTCCTGAAAGTTTCTTGCCACCGCCAACTGTCAAATCAGCCCTGTTAAACATTAAAAGAAAACACTTATTTTTTGATTTTAAGTTTAAAGCCAAATACTTAGCATTTATTTCCTGTCTGTTAGAGAAACCTGATTTATCTGTAAAAACAGCTTTAAAGTCGATTTTCAGGAAAAGTCAGGTCAGGTCAATTTCGGAAAAATTCGGTTTAAACCTTAATGCTCAAATTGTTTGTTTGTCTCCAAGTCAATGGTTAAACTGTTTTTTGGAAATGCTGGAAGTTGTCCCTGAAAAATTTCATCCTTCGTAG	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIILQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	100.00	gnl|BL_ORD_ID|586|hsp_num:0	621
NODE_71_length_44181_cov_171.274_18 # 19781 # 20341 # -1 # ID=71_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.567	NODE_71_length_44181_cov_171.274_18 	19781	20341	-	Strict	500	23.483	mphB	100.0	3000318	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGTCCCCATCGAAGCGAGCAGGCTTGGGTCTTGCGCTCACCGGGGTGCTGTCGCTCAGCGCGTGTGGAGCGGGCAACGTCAATCTTGATCCGGCTCCAGATGCCGCCAACCCCGTATGCGCTTATGCGATGGTTGCTATGCCAGAAAAACTCGTTGGCCTACAGCAGCGTGAAACTACGGCGCAAGGAACGACTGCTTGGGGCGAACCAGCCTCCGTGATTCTCAAATGCGGTGTTACCGTTCAGGAACCCGTATCGGACCCATGCGCTGAGGTCAATGGGATTGATTGGGTGCTGCGTCCCAAGGATGCGCCAGAGAACTCAGCACCGCCAGTCTCAGCGTCTTCCTCCGCCGCTGCAGGCCCTGAAAACCGTGCGACGGGAACGTGGACGGCAACCACGTACGGACGAACGCCCGCCATTGAAGTAACCTTCGACGCAGATAAGGTTTCATCATCAACTCTTCTTGCTGAGCTCAACTCGGCGGTCAAACAAATTCCGTCTCAGAAGAAATGCACGAACATCAACGATACTCTCAACGGTGTCAAAACCGGAAAATAG	MSPSKRAGLGLALTGVLSLSACGAGNVNLDPAPDAANPVCAYAMVAMPEKLVGLQQRETTAQGTTAWGEPASVILKCGVTVQEPVSDPCAEVNGIDWVLRPKDAPENSAPPVSASSSAAAGPENRATGTWTATTYGRTPAIEVTFDADKVSSSTLLAELNSAVKQIPSQKKCTNINDTLNGVKTGK	MSKDIKQVIEIAKKHNLFLKEETIQFNESGLDFQAVFAQDNNGIDWVLRLPRREDVMPRTKVEKQALDLVNKYAISFQAPNWIIYTEELIAYKKLDGVPAGTIDHNIGNYIWEIDINNVPELFHKSLGRVLAELHSIPSNKAAALDLVVHTPEEARMSMKQRMDAVRAKFGVGENLWNRWQAWLNDDDMWPKKTGLIHGDVHAGHTMIDKDANVTGLIDWTEAKVTDVSHDFIFNYRAFGEEGLEALILAYKEIGGYYWPKMKEHIIELNAAYPVSIAEFALVSGIEEYEQMAKEALEVQGS	61.59	gnl|BL_ORD_ID|1653|hsp_num:0	1731
NODE_75_length_43075_cov_12.6279_33 # 31638 # 32603 # 1 # ID=75_33;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.356	NODE_75_length_43075_cov_12.6279_33	31638	32603	+	Perfect	600	661.759	CfxA2	100.0	3003002	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	ATGGAAAAAAACAGAAAAAAACAAATCGTAGTTTTGAGTATAGCTTTAGTTTGCATTTTCATCTTGGTATTTTCATTGTTCCATAAATCAGCGACAAAAGATAGCGCAAATCCTCCTTTAACAAATGTTTTGACTGATAGCATTTCTCAAATTGTCTCAGCTTGTCCTGGCGAAATTGGTGTGGCGGTTATTGTTAATAACAGAGATACGGTTAAGGTCAATAATAAGAGTGTTTATCCTATGATGAGTGTGTTTAAGGTTCATCAGGCATTAGCTCTTTGTAATGACTTTGACAATAAAGGAATTTCACTTGATACCTTAGTAAATATAAATAGGGATAAACTTGACCCAAAGACTTGGAGTCCTATGCTGAAAGATTATTCAGGGCCAGTCATATCATTGACAGTGAGAGATTTGCTGCGTTATACTCTTACTCAGAGTGACAACAATGCAAGCAACCTTATGTTTAAGGATATGGTTAATGTCGCTCAAACAGATAGTTTTATAGCCACACTCATTCCTCGTTCAAGTTTTCAGATAGCTTATACGGAAGAGGAAATGTCGGCTGACCATAACAAGGCTTACTCTAACTATACATCTCCTCTTGGTGCTGCAATGTTGATGAATCGTTTGTTTACTGAAGGTCTTATCGATGATGAGAAACAAAGTTTCATTAAGAATACGTTAAAAGAATGCAAAACAGGTGTAGATAGGATAGCAGCTCCACTTCTTGATAAAGAAGGGGTTGTTATAGCGCATAAGACAGGTTCAGGTTATGTTAATGAAAATGGTGTTCTTGCAGCTCACAATGATGTTGCCTATATATGTCTGCCTAATAATATCAGTTATACCTTAGCGGTATTTGTTAAGGATTTCAAGGGAAATGAATCACAAGCGTCACAATATGTTGCGCATATATCAGCTGTAGTATATTCTTTATTAATGCAAACTTCAGTAAAATCTTAA	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	100.00	gnl|BL_ORD_ID|162|hsp_num:0	174
NODE_89_length_37755_cov_25.9308_5 # 4272 # 5369 # -1 # ID=89_5;partial=00;start_type=TTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.634	NODE_89_length_37755_cov_25.9308_5 	4272	5369	-	Loose	1900	26.9498	MuxB	32.56	3004074	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGAAGTACACCCTCAGAACCAGAGAGTCCGGGAAGTCCCGAGGCATGGTGATTACCCGCAGGGACCGGAGGAACCTTGAGCGGGTGGCTCGCTGGTACTCGCTGACCATCGACCACATGGCACGGATGGAGCTAGGTTGGCCTGCCTGGGCGACGATGCTGTCTAACAGCGAGGTCCCCACCGGCGGAGACCTGACCCCAATGCCTGACGGCTCTCCCGGGCAGCGCGCCTCCACCTACTACGCGACAATCAGTCGCCGAATGAGCCTGCTCTCCTCCCTCAGCGTGCCCGGGTACGACGAAGGCCTGGTCACCAGGCTCGACTCGTGGGAGCCAGGAGAGAAGACCTCCGGATGGTGGCTCACCAAAGCAGGCAAGGAGTACCTGCAAGCCCCCTACGCGATCGCGACAAGACCTGCAACCTTGAAGGCCCAGCACACCTGGGACTCAGCCGATCTGGGCAACCAGCTCGAGACCATGTTTGGGCTCGACGTGCTCTCCGAACGAGAGATGATGGCCGGCCAGACATACCGCGACGGCGAGACGCGAGAAGTGCCAGTCACCCTCTTCCAGTCACGCCGCAGAGGCGGAGGACCAAACGGAGCCCTGCCCCGAAGCAAGCGTCCAGACCTGGCCCTGCTCCACTACGACGAGCGCGGAAGAGTCTCCTTCACCGCTATCGAGGTTGAGCGCGTCGGCTCCCGCCCTATGAGGGAGTATCGAGACAAGCTTCTGACGTACATGGACGACCCCCACGTCGACGCCGTCTGGTACCTGTGCGACCGCAACTCGATCCGCAACCGCGTCCGACAAGCCATGAACGACCTCATCCAGGCCGGCGACGTCACCAACCCCTCACAGACCCCCCTCCTGGTCGACACCGTCCAGCACTGGGGGCAACCAACCAAGCAGATGCGCGACGACAACTTCACCCGACGCAACACCTCATGGGTCGGCCTACCCGGCATCGGACTAGACGGGTCCGTACTCCTCAACAGCGAAGGACAACCCTCCAACGTCGGTCAACGAACCCTGCGCATGATCCGCGCCGAGCAACAGGCACAAGACGTCCCCATGACCCCAGGAAGGAGCGCATAA	LKYTLRTRESGKSRGMVITRRDRRNLERVARWYSLTIDHMARMELGWPAWATMLSNSEVPTGGDLTPMPDGSPGQRASTYYATISRRMSLLSSLSVPGYDEGLVTRLDSWEPGEKTSGWWLTKAGKEYLQAPYAIATRPATLKAQHTWDSADLGNQLETMFGLDVLSEREMMAGQTYRDGETREVPVTLFQSRRRGGGPNGALPRSKRPDLALLHYDERGRVSFTAIEVERVGSRPMREYRDKLLTYMDDPHVDAVWYLCDRNSIRNRVRQAMNDLIQAGDVTNPSQTPLLVDTVQHWGQPTKQMRDDNFTRRNTSWVGLPGIGLDGSVLLNSEGQPSNVGQRTLRMIRAEQQAQDVPMTPGRSA	MNPSRPFILRPVATTLLMVAILLSGLIAYRFLPISALPEVDYPTIQVVTLYPGASPEIMTSSITAPLENQLGQIPGLNEMSSSSSGGASVITLQFSLQSNLDVAEQEVQAAINAAQSLLPNDLPNQPVFSKVNPADAPILTLAVMSDGMPLPQIQDLVDTRLAQKISQISGVGLVSISGGQRPAVRVRANPTALAAAGLSLEDLRSTVTSNNLNGPKGSFDGPTRASTLDANDQLRSADAYRDLIIAYKNGSPLRIRDVASVEDDAENVRLAAWANNLPAVVLNIQRQPGANVIEVVDRIKALLPQLQSTLPGNLDVQVLTDRTTTIRASVKDVQFELALAVALVVMVTFLFLRNVYATLIPSFAVPLSLIGTFGVMYLSGFSINNLTLMALTIATGFVVDDAIVMVENIARYLEQGDSPLEAALKGSKQIGFTIISLTFSLIAVLIPLLFMGDVAGRLFREFAITLAVAILISGFVSLTLTPMLSAKLLRHIDEDQQGRFARAAGRVIDGLIAQYAKALRVVLRHQPLTLLVAIATLALTALLYLAMPKGFFPVQDTGVIQGVAEAPQSISFQAMSERQRALAEVVLKDPAVASLSSYIGVDGSNPTLNTGRLLINLKPHSERDVTASEVIQRLQPELDHLPGIKLYMQPVQDLTIEDRVARTQYQFTLQDADPDVLAEWVPKLVARLQELPQLADVASDWQDKGLQAYLNIDRDTASRLGVKLSDIDSVLYNAFGQRLISTIFTQATQYRVVLEVAPQFQLGPQALEQLYVPSSDGTQVRLSSLAKVEERHTLLAINHIAQFPSATLSFNLAKGYSLGEAVEAIRGVEASLELPLSMQGSFRGAALAFEASLSNTLLLILASVVTMYIVLGILYESFIHPVTILSTLPSAGVGALLALMLAGQEIGIVAIIGIILLIGIVKKNAIMMIDFALDAERNEGKPPHEAIYQACLLRFRPILMTTMAALLGALPLMLAGGAGAELRQPLGITMVGGLLLSQVLTLFTTPVIYLYFDRLARRWAAWRKQRGLDLNTEAGFDGDAGR	35.00	gnl|BL_ORD_ID|2295|hsp_num:0	2718
NODE_343_length_12543_cov_40.2792_4 # 4555 # 4770 # 1 # ID=343_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.667	NODE_343_length_12543_cov_40.2792_4 	4555	4770	+	Loose	400	23.483	MUS-2	35.9	3003842	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MUS beta-lactamase	ATGGCACGCAAAGGATCTATGCGGGCGCAGCGGAAGCGCTGGGCGCAGTGGGAGGCGTACCGGAACGAGATGTACGTGACCGACGAGAAGGCTCTCGCCCGCGCCTACCGGGAGTACAGCCTGACCGGAGTCCTGGAGGACCCCTGGACCGGGGACCGGTACTGCCCCAGCTGCGAGAAGCCTGAGCAGTACTGCGATTGCGGCTCCGCTGCCTGA	MARKGSMRAQRKRWAQWEAYRNEMYVTDEKALARAYREYSLTGVLEDPWTGDRYCPSCEKPEQYCDCGSAA	MHRILSVITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSSNSMYVLTDEGAILIDTPWDKDQYEPLLEYIRSNHNKEVKWVITTHFHEDRSGGLGYFNSIGAQTYTYALTNEILKERNEPQAQYSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKSAEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMIGHIENTERILSAYNQQHSTKND	28.86	gnl|BL_ORD_ID|2169|hsp_num:0	2328
NODE_408_length_11214_cov_193.979_10 # 7663 # 9009 # -1 # ID=408_10;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.561	NODE_408_length_11214_cov_193.979_10 	7663	9009	-	Loose	1300	25.7942	vanTG	40.91	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGAGCGAATCCGTAGCCGGACAGAACACCGGCAGCACGCATCAAAAGCTAAAGACAATCGAGCGAGAACACGAGGCGCAGGCGCAAAAATTAGCCCGTACCGGTGTACCCTACGCTCTTAATACCGCAGCGGCATGGTCGTGGCGTCTGATCGTGGTGGTCGGTGCCGTGTGGCTTGTATGGCAGGGGCTTTCAAAGGTGTCTCTGCTGATTATTTCGGCGATGGTAGCTGCGCTTTTGGCTGCGCTTCTAAGCCCCGCCGTCTACGCTATGCGTAAGCACGGTATTCGTGCTGGCGGTGCGACCGCTATTGCCGAACTCGGCATGATTTTAGGAATTGCCGCTTTACTGGCCCTTACCGGGCAGCAGCTTGTGCGGGGGTTTGTCTCGCTTACCAACAACGCCATTCAAGGGTATCAGCAGCTCGTGGACTGGCTTAAGGGCATGGGTTATGAGCTGGGCGCTGATCAGCTTAACCAGATTCTTAATCAGATAGAACAGGCGGTAAGCAATAACCCCTCAACCGTTTTGCGGAGCGTATCAGAGGTTGGTTCTACCGCTGCGGAGTTTGCCACCGGCGTGCTTATTACTCTTTTTACCCTCGTCTTCTTCCTGATGGAGGGAGAGCGCATCTGGCTGTTTATCGTCAAGCTCTTCCCACAACAGGCACGCGATGCGGTGAACGGCGCGGGTCGTGCAGGGTGGAAGTCCCTGGGCGCTTATGTGCGGGTGCAGATCTTGGTGGCCGCTATTGACGCTGTGGGCATTGGTGTTGGCGCCGCCATTTTGGGGGTTCCGCTGGCGATTCCGCTGGGCGTTCTGGTTTTCTTAGGGTCTTTTATTCCGGTTATTGGTGCTCTTATTTCTGGGGCGGTCGCCGTCCTGCTGGCACTGGTAGCTTTGGGACCGGTTCAGGCGCTCATTATGATCGGCATTGTGCTGTTGGTGCAGCAGCTTGAATCGCATATTCTGCAGCCGCTCATCATGGGTAAAGCGGTCTCGCTGCATCCACTCGCCGTGATTTTTGCGGTGGCAGGCGGGTCCATGATTTTCGGTGCAGCGGGTGCACTATTTGCGGTTCCCGTGCTCGCCGTTGTGAACTCGGTTGTGCGCTACTTGGCCGCGCGGCAGTGGGAGGATGACCCGGAGCTGCGCCGTGAAGAGTTCCTATTCCCGCATGAGGTTGAGCGCCGTGAGAAATCAAAGAAGCGTGAAGAAAAAGCACAGAAGGTTGTTGCGCAGGCGCGAGAAGCAATTCGTGGTGAAGACGATTCCGAAGGCACCGCACCTGAGACTAGCTCTGCACAAGTGACTAAAACCGTCTCGTCTTCCAAGGACGATACATAA	VSESVAGQNTGSTHQKLKTIEREHEAQAQKLARTGVPYALNTAAAWSWRLIVVVGAVWLVWQGLSKVSLLIISAMVAALLAALLSPAVYAMRKHGIRAGGATAIAELGMILGIAALLALTGQQLVRGFVSLTNNAIQGYQQLVDWLKGMGYELGADQLNQILNQIEQAVSNNPSTVLRSVSEVGSTAAEFATGVLITLFTLVFFLMEGERIWLFIVKLFPQQARDAVNGAGRAGWKSLGAYVRVQILVAAIDAVGIGVGAAILGVPLAIPLGVLVFLGSFIPVIGALISGAVAVLLALVALGPVQALIMIGIVLLVQQLESHILQPLIMGKAVSLHPLAVIFAVAGGSMIFGAAGALFAVPVLAVVNSVVRYLAARQWEDDPELRREEFLFPHEVERREKSKKREEKAQKVVAQAREAIRGEDDSEGTAPETSSAQVTKTVSSSKDDT	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	62.92	gnl|BL_ORD_ID|1488|hsp_num:0	1561
NODE_417_length_11063_cov_39.1405_4 # 4560 # 4775 # 1 # ID=417_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.662	NODE_417_length_11063_cov_39.1405_4 	4560	4775	+	Loose	400	22.7126	MUS-2	35.9	3003842	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MUS beta-lactamase	ATGCCTCGTGGAAACACCAAGAAGGAGCAGCGCAAGCGCTGGGCGCAGTGGGAGGCGTACCGAAACGAGATGTACGTGACCGACGAGAAGGCCCTCGCCCGCGCCTACCGCGAGTACAGCCTGACTGGCGTACTGGAGGACCCGTGGACCGGGGACCGGTACTGCCCGTCCTGCGAGAAGCCCGAGCAGTACTGCGACTGCGGCTCCGTCGCCTGA	MPRGNTKKEQRKRWAQWEAYRNEMYVTDEKALARAYREYSLTGVLEDPWTGDRYCPSCEKPEQYCDCGSVA	MHRILSVITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSSNSMYVLTDEGAILIDTPWDKDQYEPLLEYIRSNHNKEVKWVITTHFHEDRSGGLGYFNSIGAQTYTYALTNEILKERNEPQAQYSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKSAEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMIGHIENTERILSAYNQQHSTKND	28.86	gnl|BL_ORD_ID|2169|hsp_num:0	2328
NODE_528_length_9201_cov_10.9876_12 # 9134 # 9199 # -1 # ID=528_12;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.485	NODE_528_length_9201_cov_10.9876_12 	9134	9199	-	Loose	275	19.631	AAC(6')-IIa	52.94	3002594	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATTGACATCCACACGCCCACGCTGGACGAAGTGTATGCCGAGTTTTTAAAACGAGAAGACGTGTAA	IDIHTPTLDEVYAEFLKREDV	MSASTPPITLRLMTERDLPMLHDWLNRPHIVEWWGGDEERPTLDEVLEHYLPRAMAEESVTPYIAMLGEEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQSLADPTQLNKGLGTRLVRALVELLFSDPTVTKIQTDPTPNNHRAIRCYEKAGFVREKIITTPDGPAVYMVQTRQAFERKRGVA	11.41	gnl|BL_ORD_ID|1585|hsp_num:0	1657
NODE_906_length_5911_cov_6.61066_6 # 1955 # 3418 # -1 # ID=906_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_906_length_5911_cov_6.61066_6	1955	3418	-	Perfect	950	989.178	mel	100.0	3000616	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGAATTAATATTAAAAGCAAAAGACATTCGTGTGGAATTCAAAGGACGCGATGTTTTAGATATAAATGAATTAGAAGTATATGATTATGACCGTATTGGTTTAGTAGGAGCAAATGGTGCTGGAAAAAGCACTTTACTCAGGGTACTTTTAGGAGAATTAACTCCCCCAGGATGTAAAATGAATCGTCTGGGTGAACTTGCCTATATTCCCCAGTTGGACGAAGTAACTCTGCAGGAGGAAAAAGATTTTGCACTTGTAGGCAAGCTAGGTGTTGAGCAATTAAATATACAGACTATGAGCGGTGGTGAAGAAACAAGGCTTAAAATAGCACAGGCCTTATCGGCACAGGTTCATGGTATTTTAGCGGATGAACCTACGAGCCATTTAGACCGTGAAGGAATTGATTTTCTAATAGGACAGCTAAAATATTTTACAGGTGCACTGTTAGTTATTAGCCATGACCGCTATTTTCTTGATGAAATAGTAGATAAAATATGGGAACTGAAAGATGGCAAAATCACTGAGTATTGGGGAAACTATTCTGATTATCTTCGTCAGAAAGAGGAAGAACGTAAGAGCCAAGCTGCAGAATACGAACAATTTATTGCGGAACGTGCCCGATTGGAAAGGGCTGCGGAGGAAAAGCGAAAACAGGCTCGTAAAATAGAACAGAAGGCAAAAGGTTCTTCAAAGAAAAAAAGTACTGAAGACGGAGGGCGTTTAGCTCATCAAAAATCAATAGGAAGTAAGGAAAAAAAGATGTATAATGCTGCTAAAACCCTAGAGCACAGGATTGCGGCCTTAGGAAAAGTAGAAGCTCCGGAAGGCATTCGCAGAATTCGTTTCAGGCAAAGTAAAGCATTGGAGCTCCATAATCCATACCCTATAGTCGGTGCAGAAATTAATAAAGTATTTGGGGATAAGGCTCTGTTTGAAAATGCATCTTTTCAAATTCCGTTAGGAGCAAAAGTGGCGTTAACTGGTGGTAATGGAATCGGAAAAACAACTTTAATCCAAATGATCTTAAACCATGAAGAAGGAATTTCTATTTCGCCTAAGGCAAAAATAGGTTACTTTGCACAGAATGGTTACAAGTACAACAGTAATCAGAATGTTATGGAGTTTATGCAGAAGGATTGTGACTACAATATATCAGAAATTCGTTCAGTGCTAGCATCTATGGGGTTCAAACAGAACGATATTGGAAAAAGTTTATCTGTTTTAAGCGGTGGAGAAATTATAAAATTGTTGCTTGCTAAAATGCTCATGGGTAGATATAACATCCTAATAATGGATGAACCCAGTAACTTCCTTGACATACCAAGTTTAGAGGCTTTGGAAATACTAATGAAGGAGTACACCGGAACTATCGTGTTTATCACCCACGATAAACGATTACTCGAAAATGTAGCAGATGTAGTTTATGAAATTAGAGATAAGAAAATAAATCTGAAACATTAA	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	100.00	gnl|BL_ORD_ID|1177|hsp_num:0	1231
NODE_906_length_5911_cov_6.61066_7 # 3538 # 4755 # -1 # ID=906_7;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_906_length_5911_cov_6.61066_7 	3538	4755	-	Strict	800	780.015	mefA	96.3	3000615	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAAAAATACAACAATTGGAAACGAAAATTTTATGCAATATGGGCAGGGCAAGCAGTATCATTAATCACTAGTGCCATCCTGCAAATGGCGATTATTTTTTACCTTACAGAAAAAACAGGATCTGCGATGGTCTTGTCTATGGCTTCATTAGTAGGTTTTTTACCCTATGCGATTTTGGGACCTGCCATTGGTGTGCTAGTGGATCGTCATGATAGGAAGAAGATAATGATTGGTGCCGATTTAATTATCGCAGCAGCTGGTGCAGTGCTTGCTATTGTTGCATTCTGTATGGAGCTACCTGTCTGGATGATTATGATAGTATTGTTTATCCGTAGCATTGGAACAGCTTTTCATACCCCAGCACTCAATGCGGTTACACCACTTTTAGTACCAGAAGAACAGCTAACGAAATGCGCAGGCTATAGTCAGTCTTTGCAGTCTATAAGCTATATTGTTAGTCCGGCAGTTGCAGCACTCTTATACTCCGTTTGGGATTTAAATGCTATTATTGCCATCGACGTATTGGGTGCTGTGATTGCATCTATTACGGTAGCAATTGTACGTATACCTAAGCTGGGTAATCAAGTGCAAAGTTTAGAACCAAATTTCATAAGGGAGATGAAAGAAGGAGTTGTGGTTCTGAGACAAAACAAAGGATTGTTTGCCTTATTACTCTTAGGAACACTATATACTTTTGTTTATATGCCAATCAATGCACTATTTCCTTTAATAAGCATGGAACACTTTAATGGAACGCCTGTGCATATTTCTATTACGGAAATTTCCTTTGCATTTGGGATGCTAGCAGGAGGCTTATTATTAGGAAGATTAGGGGGCTTCGAAAAGCATGTATTACTAATAACAAGTTCATTTTTTATAATGGGGACCAGTTTAGCCGTTTCGGGAATACTTCCTCCAAATGGATTTGTAATATTCGTAGTTTGCTGTGCAATAATGGGGCTTTCGGTGCCATTTTATAGCGGTGTGCAAACAGCTCTTTTTCAGGAGAAAATTAAGCCTGAATATTTAGGACGTGTATTTTCTTTGATCGGAAGTATCATGTCACTTGCTATGCCAATTGGGTTAATTCTTTCTGGATTCTTTGCTGATAAAATCGGTGTAAATCATTGGTTTTTACTATCAGGTATTTTAATTATTGGCATTGCTATAGTTTGCCAAATGATAACTGAGGTTAGAAAATTAGATTTAAAATAA	MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAILGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMPIGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK	MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGIVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEYFNGTPVHISITEISFAFGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK	100.00	gnl|BL_ORD_ID|1891|hsp_num:0	1976
NODE_1151_length_4968_cov_2.37757_1 # 1 # 84 # -1 # ID=1151_1;partial=10;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=3-4bp;gc_cont=0.702	NODE_1151_length_4968_cov_2.37757_1 	1	84	-	Strict	920	19.631	OpmD	100.0	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; acridine dye	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCACCGACTATCAACGTCCGCAGAGCCGGGCGGCATCGCTTCCCGGCGTCGCCCCATCGGCATCGCGCGATGTCGAGGGC	MPTDYQRPQSRAASLPGVAPSASRDVEG	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	5.75	gnl|BL_ORD_ID|413|hsp_num:0	442
NODE_2365_length_2950_cov_2.44214_5 # 2761 # 2949 # 1 # ID=2360_5;partial=01;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.598	NODE_2365_length_2950_cov_2.44214_5 	2761	2949	+	Loose	1020	50.0618	vgaD	47.27	3002832	protein homolog model	n/a	n/a	streptogramin antibiotic; pleuromutilin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGCTAGTATTTTCGCTTGTGATCGTGACCAATGACTTTGAAGTTCGGGTGGGCGCCAGGACCCTCCTAACCGCCCCTAAACAACAGCTCCGAGTCCAACCCGGTGACCGCATTGGCCTGGTGGGTCGCAACGGCGCCGGAAAAACCACCACCATGCGCATACTGGCGGGCGAAACCGAACCCTACGGC	VLVFSLVIVTNDFEVRVGARTLLTAPKQQLRVQPGDRIGLVGRNGAGKTTTMRILAGETEPYG	MLILEANHIEKSINDRKLLDVTHLQIHYEDRIGVVGRNGSGKTTLLSILAGEIEADKGEVKTSASRYFLPQLKETDTFRSGGEITKSYIDKALAMKAEILFADEPTTNLDTHNIKELEKHFSRYRGAIILVSHNRYFLDQICTKIWEIEDGEVKEIHGNYTSYVKQKELLRRQQQEEYEKYITKKKQLERAVTMKEQKAQKMIKPPSKQMGTSESRIWKMQHATKQKKMHQNIKALETRVEKLERVKKPKDYPAVKMKLSNQDQIQGRNVLRVKDLSVSFGNHVLWTDASFTIKGGEKAAIIGNNGVGKTTLLKQILERVPAVTISPAAKIGYFSQNLDTLDTHVSILENVMSTAIQDETTVRTVLARLHFYREDVYKEVQVLSGGERVKVAFAKLFVSDYNTLILDEPTNYLDIDAIEALEELLINYEGAVLFVSHDCRFVQNIASKIIELSDQKVIEFLGSYKAFRERSQETERDYMKEELLKIEIKLTQMISEMNDEASNELEKEFQMLIHERNQLRNQVNN	12.00	gnl|BL_ORD_ID|1002|hsp_num:0	1046
NODE_2705_length_2659_cov_2.42358_6 # 2600 # 2659 # 1 # ID=2695_6;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.450	NODE_2705_length_2659_cov_2.42358_6 	2600	2659	+	Loose	400	20.0162	IMP-24	80.0	3002215	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGCAAATTATTCTGTTAGAGAAAATCGGCGGTTTGGGCAACTTGGGCGACATCGTTACC	MQIILLEKIGGLGNLGDIVT	MKKLFVLCVCFLCSITAAGAALPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNTDAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKPDGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESRKPSQPSN	8.13	gnl|BL_ORD_ID|1667|hsp_num:0	1746
NODE_3012_length_2329_cov_3.24622_1 # 77 # 1996 # -1 # ID=2992_1;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.531	NODE_3012_length_2329_cov_3.24622_1	77	1996	-	Strict	1200	1312.36	tetW	99.84	3000194	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAAATAATCAATATTGGAATTCTTGCCCATGTAGACGCTGGAAAGACGACCTTGACGGAGAGCCTGCTATATGCCAGCGGAGCCATTTCAGAACCGGGGAGCGTCGAAAAAGGGACAACGAGGACGGACACCATGTTTTTGGAGCGGCAGCGTGGGATTACCATTCAAGCGGCAGTCACTTCCTTCCAGTGGCACAGATGTAAAGTTAACATTGTGGATACGCCCGGCCACATGGATTTTTTGGCGGAGGTGTACCGCTCTTTGGCTGTTTTAGATGGGGCCATCTTGGTGATCTCCGCTAAAGATGGCGTGCAGGCCCAGACCCGTATTCTGTTCCATGCCCTGCGGAAAATGAACATTCCCACCGTTATCTTTATCAACAAGATCGACCAGGCTGGCGTTGATTTGCAGAGCGTGGTTCAGTCTGTTCGGGATAAGCTCTCCGCCGATATTATCATCAAGCAGACGGTGTCGCTGTCCCCGGAAATAGTCCTGGAGGAAAATACCGACATAGAAGCATGGGATGCGGTCATCGAAAATAACGATGAATTATTGGAAAAGTATATCGCAGGAGAACCAATCAGCCGGGAAAAACTTGCGCGGGAGGAACAGCAGCGGGTTCAAGACGCCTCCCTGTTCCCAGTCTATCATGGCAGCGCCAAAAATGGCCTTGGCATTCAACCGTTGATGGATGCGGTGACAGGGCTGTTCCAACCGATTGGGGAACAGGGGGGCGCCGCCCTATGCGGCAGCGTTTTCAAGGTTGAGTACACCGATTGCGGCCAGCGGCGTGTCTATCTACGGTTATACAGCGGAACGCTGCGCCTGCGGGATACGGTGGCCCTGGCCGGGAGAGAAAAGCTGAAAATCACAGAGATGCGTATTCCATCCAAAGGGGAAATTGTTCGGACAGACACCGCTTATCAGGGTGAAATTGTTATCCTTCCCAGCGACAGCGTGAGGTTAAACGATGTATTAGGGGACCAAACCCGGCTCCCTCGTAAAAGGTGGCGCGAGGACCCCCTCCCCATGCTGCGGACGACGATTGCGCCGAAAACGGCAGCGCAAAGAGAACGGCTGCTGGACGCTCTTACGCAACTTGCGGATACTGACCCGCTTTTGCGTTGCGAAGTGGATTCCATCACCCATGAGATCATTCTTTCTTTTTTGGGCCGGGTGCAGTTGGAGGTTGTTTCCGCTTTGCTGTCGGAAAAATACAAGCTTGAAACAGTGGTAAAGGAACCCTCCGTCATTTATATGGAGCGGCCGCTCAAAGCAGCCAGCCACACCATCCATATCGAGGTGCCGCCCAACCCGTTTTGGGCATCCATAGGACTGTCTGTTACACCACTCTCGCTTGGCTCCGGTGTACAATACGAGAGCCGGGTTTCGCTGGGATACTTGAACCAGAGTTTTCAAAACGCTGTCAGGGATGGTATCCGTTACGGGCTGGAGCAGGGCTTGTTCGGCTGGAACGTAACGGACTGTAAGATTTGCTTTGAATACGGGCTTTATTACAGTCCGGTCAGCACGCCGGCGGACTTCCGCTCATTGGCCCCGATTGTATTGGAACAGGCATTGAAGGAATCGGGGACGCAGCTGCTGGAACCTTATCTCTCCTTCATCCTCTATGCGCCCCAGGAATACCTTTCCAGGGCTTATCATGATGCACCGAAATACTGTGCCACCATCGAAACGGCCCAGGTAAAAAAGGATGAAGTTGTCTTTACTGGCGAGATTCCCGCCCGCTGTATACAGGCATACCGTACTGATCTGGCCTTTTACACCAACGGGCGGAGCGTATGCCTTACAGAGCTGAAAGGATATCAGGCCGCTGTCGGTCAGCCGGTCATCCAGCCCCGCCGTCCAAACAGCCGCCTGGACAAGGTGCGCCATATGTTTCAGAAGGTAATGTAA	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALGGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM	100.00	gnl|BL_ORD_ID|364|hsp_num:0	389
NODE_3075_length_2400_cov_3.28785_4 # 1353 # 1652 # -1 # ID=3053_4;partial=00;start_type=ATG;rbs_motif=AACAA;rbs_spacer=7bp;gc_cont=0.437	NODE_3075_length_2400_cov_3.28785_4 	1353	1652	-	Loose	1650	23.483	Brucella suis mprF	30.23	3003772	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGGTAAATATCAACATCGAACCAATCCAGAAAGGCAACATCATGATTAGATCCACAGACAAACGACACGAATTGATTGTCGAGCCCTGTCTCGTTCATAACGACGTGTTCAGATGTATCGTTCTCCGAGACAATATGATTGTCGAGGTTTCGCGCCAACATCTTCATTCTTTCTTTGCTGTCATGTCGTCCGACAGTATTCCGCTCTACCTGACCATCGGTGTCCACGGTAGAACAATCAGATTCGATTTCGAGGAGTTTACGCATGAGCTTCAAGCTGCTTATGACGCTTTTTTCTAA	MVNINIEPIQKGNIMIRSTDKRHELIVEPCLVHNDVFRCIVLRDNMIVEVSRQHLHSFFAVMSSDSIPLYLTIGVHGRTIRFDFEEFTHELQAAYDAFF	MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRHTSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAGYAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQDVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAGVVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLGGKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSASIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRLERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNWIATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSIINRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSLIALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARVDLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEKGFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDALFAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKEKFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK	11.25	gnl|BL_ORD_ID|2130|hsp_num:0	2281
NODE_3130_length_2373_cov_2.96851_1 # 2 # 199 # 1 # ID=3106_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.561	NODE_3130_length_2373_cov_2.96851_1 	2	199	+	Loose	400	21.1718	IMP-27	32.2	3002218	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	GTATTGTCTATGGGTTCGTGTGCCAATGGCGGCGGATACTATCATTATTCTTATTCCGTCGTGCGCGGTGCCGACCGTGTCGTGCCGGTAGACGTTTATGTGCCGGGTTGCCCGCCGACTGCGGAAGCTCTGATTTACGGCCTGATGCAGCTCCAACAAAAAATCAAGCGCACTTCCACCATCGCGCGGGACGAGTAG	VLSMGSCANGGGYYHYSYSVVRGADRVVPVDVYVPGCPPTAEALIYGLMQLQQKIKRTSTIARDE	MKKLFVLCVFVFCSITVAGETLPNLRVEKLEEGVYVHTSYEEVKGWGVVTKHGLVVLIGADAYLIDTPFTAKDTEKLVNWFVERGYKIKGTVSSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFDGVSYWLAKDKIEVFYPGPGHTQDNVVVWLPEKEILFGGCFVKPHGLGNLGDANLEAWPESAKILMEKYGKAKLVVSGHSETGDATHLKRTWEQAVKGLKESKKTLQPSN	26.42	gnl|BL_ORD_ID|1918|hsp_num:0	2006
NODE_3527_length_2172_cov_2.10061_4 # 2104 # 2172 # -1 # ID=3492_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.435	NODE_3527_length_2172_cov_2.10061_4 	2104	2172	-	Strict	700	18.0902	DHA-5	100.0	3002138	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	DHA beta-lactamase	CCGATCTTAAAGGTGTTCGACTGGCTGACGGAGGTGTTGTGGGAAATGTATGATAAAAAGGCTACTTGA	PILKVFDWLTEVLWEMYDKKAT	MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGRPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLHFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	5.80	gnl|BL_ORD_ID|1621|hsp_num:0	1695
NODE_3731_length_2077_cov_3.15529_1 # 3 # 62 # -1 # ID=3686_1;partial=10;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.517	NODE_3731_length_2077_cov_3.15529_1 	3	62	-	Strict	400	18.8606	msrA	100.0	3000251	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAACGGTAAATACTACTACGGCACAGGCCGCCGCAAAAGTTCAGTGGCTCGTGTATTC	MNGKYYYGTGRRKSSVARVF	MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKQKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT	4.10	gnl|BL_ORD_ID|1149|hsp_num:0	1200
NODE_5326_length_1542_cov_2.26765_2 # 162 # 326 # 1 # ID=5166_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.612	NODE_5326_length_1542_cov_2.26765_2 	162	326	+	Loose	2300	22.7126	evgS	36.36	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAAAAATCATCCTTGCCGCGCTCGCAGCAGCAACCATCGGTACTGCCTCCGCCGCCACCTACAAAGTGGACGAACACCACGCCAACGCCCGTTTCGCCATCGACCACTTCAACACCAGCACCAACGTCGGCGGTTTTTACGGCCNNNNNNNNNNGGCCTGA	MKKIILAALAAATIGTASAATYKVDEHHANARFAIDHFNTSTNVGGFYGXXXXA	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	4.51	gnl|BL_ORD_ID|1261|hsp_num:0	1318
NODE_6530_length_1280_cov_2.31755_1 # 90 # 278 # 1 # ID=6224_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.439	NODE_6530_length_1280_cov_2.31755_1 	90	278	+	Loose	800	23.8682	lmrP	32.5	3003969	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCGGATATTACCTTATTGGAAGAAATTTCTGAGCAGGATCTTCATCAGGCGAATGGGGGTAGTCTATTTGCTTCTCCTGCGGATCCCGCAGGTGTCATTTTGTCTGCAGGCTATACAGCATATAGCTGGCTGAAAGGTAATGAAGGTATTGCGTGTACCGCTACTAAAGAGTGTAACTGTAACTAA	MSDITLLEEISEQDLHQANGGSLFASPADPAGVILSAGYTAYSWLKGNEGIACTATKECNCN	MQEFLNLPKQIQLRQLVRFVTITLGSSIFPFMAMYYTTYFGTFWTGLLMMITSLMGFVGTLYGGHLSDALGRKKVIMIGSVGTTLGWFLTILANLPNAAIPWLTFAGILLVEIASSFYGPAYEAMLIDLTDESNRRFVYTINYWFINIAVMFGAGLSGLFYDHHFLALLVALLLVNVLCFGVAYYYFDETRPETHAFDHGKGLLASFQNYRQVFQDRAFVLFTLGAIFSGSIWMQMDNYVPVHLKLYFQPTAVLGFQVTSSKMLSLMVLTNTLLIVLFMTVVNKLTEKWKLLPQLVVGSLLFTLGMLLAFTFTQFYAIWLSVVLLTFGEMINVPASQVLRADMMDHSQIGSYTGFVSMAQPLGAILASLLVSVSHFTGPLGVQCLFVVIALLGIYFTVVSAKMKKV	15.27	gnl|BL_ORD_ID|2227|hsp_num:0	2435
NODE_6680_length_1255_cov_2.66667_1 # 1 # 147 # -1 # ID=6349_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.456	NODE_6680_length_1255_cov_2.66667_1 	1	147	-	Loose	725	24.2534	AQU-1	35.71	3002993	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	AQU beta-lactamase	ATGTTTGACGGCATTATTCTGTATAATGCCGCAATGTTTTTGAAACAAGGAATACAAATGCTTACCCCAGAACAAGTCAAATCGCTGATTGAAGGCGTTGCCGCTTGCGAACACGTCGAAGTCGAAGGCGACGGACATCACTTTTTC	MFDGIILYNAAMFLKQGIQMLTPEQVKSLIEGVAACEHVEVEGDGHHFF	MKQTSPLSSLALSALLLSPLTQAAPADPLVGVVDEVIRPLVKEHRIPGMAVAVFKEGQPHYFNYGVAELATGKKVSEQTLFEIGSVSKTYTATLGAYAVVKGSIGLDDKVSRHAPWLKGSAFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFGYLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLADEAYGIKTSSADLLAFVKANINGVDDKGLQQAIALTHQGRYSVGEMTQGLGWESYPYPVSEQTLLAGNSVQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANRNYPIQERVKAAHSILSKLAP	12.89	gnl|BL_ORD_ID|1635|hsp_num:0	1711
NODE_7002_length_1203_cov_3.90592_1 # 149 # 910 # -1 # ID=6619_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.379	NODE_7002_length_1203_cov_3.90592_1 	149	910	-	Loose	500	26.1794	OXA-328	68.42	3001516	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGATGAAGAAAAAACCTATTCTCTTGCTTTTAGCAGCTTCCGTAGTTTTCCTTCTGTTTTTATCAGCCTGCAGCTCCAATAAGGGAGGCGATACTAATGGTTCCAGTTCCGAAGTGCAAAAAACGAAAGAGGGAATTTATGAGCATCTAAAAAATGCAAAGAATGAAATTTGGTATGTAACTAAGGAAGTATCAAAAACCTCTTATCCTTCTTATATCTATATCTTCAACAAGGGAGAAGTCAAAGGTTATAATTTATTTGATGCTAATATAGAAGGGAAATCTTTCGGAGATTTAGCGCAGATGTCCGATAAGGAAATTATTGATTACTATGAAAGTCAGGAAGGGGCAGCTTTAAAAGGTCTCTCTGAGCAGGCAGATTCGTTTTATGCGAGTATCAATCAAAATGAGGTGTCTAAGGCAACATCTGAAGCGTATAAAAAATACGCAGACGGGAATGGCGAGCTTCCTGCTGTTAAGTACACGGTTAAGCTAGTGACAGATGAAAGTGGGACTGGTGTCGAAAGTGAGAATATCGATATCAATCTCTTGGGTGTCGGGCAACATGCATCAAGAGTTGGAGAATTTCCACATTATACTGCTGTCTTGAAGCATGTAACAAGCACTACTAAGATTTTTGATAGCACCTATAATGGTTTTGAAACAGAGGATGCTGCGAAACCTTTATTTGTTACTCGTAGTAAAAAGCAGTTTGACTTAGATACTACTAAAACAAATGCTAAGGGACTGGAAATAGAATAA	MMKKKPILLLLAASVVFLLFLSACSSNKGGDTNGSSSEVQKTKEGIYEHLKNAKNEIWYVTKEVSKTSYPSYIYIFNKGEVKGYNLFDANIEGKSFGDLAQMSDKEIIDYYESQEGAALKGLSEQADSFYASINQNEVSKATSEAYKKYADGNGELPAVKYTVKLVTDESGTGVESENIDINLLGVGQHASRVGEFPHYTAVLKHVTSTTKIFDSTYNGFETEDAAKPLFVTRSKKQFDLDTTKTNAKGLEIE	MYKKALIVATSLLFLSACSSNTVTQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGKTEEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLGNAMKASAIPVYQELAQRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQFAYQLAHKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL	92.67	gnl|BL_ORD_ID|576|hsp_num:0	611
NODE_10566_length_835_cov_4.01923_3 # 692 # 835 # -1 # ID=9350_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.694	NODE_10566_length_835_cov_4.01923_3 	692	835	-	Loose	450	21.557	TUS-1	37.5	3000844	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin	antibiotic inactivation	TUS beta-lactamase	TACGTGACCGACGAGAAGGCCCTCGCCCGCGCCTACCGCGAGTACAGCCTGACCGGGGTCCTGGAGGACCCGTGGACCGGGGACCGGTACTGCCCCTCCTGCGAGAAGCCCGAGCAGTACTGCGACTGCGGCTCCGCCGCCTGA	YVTDEKALARAYREYSLTGVLEDPWTGDRYCPSCEKPEQYCDCGSAA	MYHYFSSLFVLIFSTLVYPQSDKLKIEPLNDHMYVYTTYQVFQGVEYSSNALYVVTDEGVILIDTPWDKDQYAPLVEHIRREHNKEIKWVITTHFHEDRSGGLDYFNKAGAETYTYALTNEILKQRNEPQATFTFGSTKQFNLGKEKIEVYFLGEGHSKDNTVVWFPEEAILYGGCLIKSAEATTIGNIVDGNVEAWPTTIKAVKRKFKKAKVIIPGHDAWNQSGHLENTARILSAYQAQKLKNNKQL	18.95	gnl|BL_ORD_ID|367|hsp_num:0	392
NODE_12751_length_705_cov_2.01538_2 # 596 # 703 # -1 # ID=10814_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.426	NODE_12751_length_705_cov_2.01538_2 	596	703	-	Strict	275	20.4014	AAC(6')-It	100.0	3002564	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GGGTATCCGACCAAATTACACTTAGAAAAGTTAGCGGAACTAGGACCTTTACCTGAGTATCGTCGTAGTTTTTCGCCGGTGAAGAAAGCATTAGGCATAGAAGAATAG	GYPTKLHLEKLAELGPLPEYRRSFSPVKKALGIEE	MHIMPITESQLSDWLVLRCLLWPDHEDADLQEMRQLITQAHCLQLLAYTNTQKAIGMLEASIRYEYVNGTQTSPVAFLEGIYVLPEYRRSGIATGLVQHVEIWAKQFACTEFASDATLDNQISHAMHRALGFHETERVVYFKKNIG	23.97	gnl|BL_ORD_ID|1600|hsp_num:0	1674
NODE_13629_length_669_cov_2.20033_1 # 2 # 88 # -1 # ID=11355_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.690	NODE_13629_length_669_cov_2.20033_1 	2	88	-	Loose	550	19.631	SHV-123	50.0	3001170	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	ATGAATGCGCACTCAACGCTCGACTCCACCGGTTGGCCTCGTCGCGGTGAGGACGGACCGGCGGTTGTGGCGCTCGGTGGGGGGCAC	MNAHSTLDSTGWPRRGEDGPAVVALGGGH	MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGGNIKAERIVVIYLRDTPASMAERNQ	10.70	gnl|BL_ORD_ID|1504|hsp_num:0	1578
NODE_19047_length_504_cov_2.56125_2 # 381 # 503 # -1 # ID=14157_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.626	NODE_19047_length_504_cov_2.56125_2 	381	503	-	Loose	500	20.7866	OXA-46	35.71	3001797	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GGCAAGCTCTATGGCCATGTGGCTGACGATGCCATGGCTCTGAAGTACGCCCACCAGCGCTACTCCGCCTACATGTCCTGGCTGGAATGGGATTCCGGCTCGTCCGCTGGAGCCGGCCCGTGA	GKLYGHVADDAMALKYAHQRYSAYMSWLEWDSGSSAGAGP	MAIRFFTILLSTFFLTSFVYAQEHVVIRSDWKKFFSDLQAEGAIVIADERQAKHTLSVFDQERAAKRYSPASTFKIPHTLFALDADAVRDEFQVFRWDGVNRSFAGHNQDQDLRSAMRNSTVWVYELFAKDIGEDKARRYLKQIDYGNVDPSTIKGDYWIDGNLKISAHEQILFLRKLYRNQLPFKVEHQRLVKDLMITEAGRSWILRAKTGWEGRFGWWVGWIEWPTGPVFFALNIDTPNRTDDLFKREAIARAILRSIDALPPN	15.04	gnl|BL_ORD_ID|360|hsp_num:0	385
NODE_1337_length_4466_cov_2.92292_4 # 2892 # 3266 # -1 # ID=1337_4;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.672	NODE_1337_length_4466_cov_2.92292_4 	2892	3266	-	Strict	200	219.55	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin	86.18	3003395	protein variant model	K88R	n/a	aminoglycoside antibiotic	antibiotic target alteration	antibiotic resistant rpsL	GTGCCCACAATTCAGCAGCTGGTCCGCAAGGGCCGCTCGAGCAAAGTCGGGAAGTCCAAGACCCCGGCGCTCAAGGGGAGTCCCCAGCGCCGCGGCGTGTGCACCCGCGTCTTCACCACCACCCCGAAGAAGCCGAATTCGGCCCTTCGCAAGGTCGCCCGCGTCCGCCTGTCCTCCGGCATAGAGGTCACGGCCTACATTCCCGGCGAGGGGCACAATCTCCAGGAGCATTCGATCGTCCTCGTCCGCGGGGGCCGCGTCCGCGACCTCCCGGGTGTGCGCTACAGGATCGTCCGTGGCGCCCTCGACACCCAGGGAGTCAAGAACCGTCAGCAGGCCCGCAGCCGCTACGGCGCGAAGAAGGAGAAGAAGTAA	VPTIQQLVRKGRSSKVGKSKTPALKGSPQRRGVCTRVFTTTPKKPNSALRKVARVRLSSGIEVTAYIPGEGHNLQEHSIVLVRGGRVRDLPGVRYRIVRGALDTQGVKNRQQARSRYGAKKEKK	MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQVEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEKG	100.00	gnl|BL_ORD_ID|2026|hsp_num:0	1197
